Literature DB >> 8127952

Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.

D E Thompson1, K Mabuchi, E Ron, M Soda, M Tokunaga, S Ochikubo, S Sugimoto, T Ikeda, M Terasaki, S Izumi.   

Abstract

This report presents, for the first time, comprehensive data on the incidence of solid cancer and risk estimates for A-bomb survivors in the extended Life Span Study (LSS-E85) cohort. Among 79,972 individuals, 8613 first primary solid cancers were diagnosed between 1958 and 1987. As part of the standard registration process of the Hiroshima and Nagasaki tumor registries, cancer cases occurring among members of the LSS-E85 cohort were identified using a computer linkage system supplemented by manual searches. Special efforts were made to ensure complete case ascertainment, data quality and data consistency in the two cities. For all sites combined, 75% of the cancers were verified histologically, 6% were diagnosed by direct observation, 8% were based on a clinical diagnosis, and 12.6% were ascertained by death certificate only. A standard set of analyses was carried out for each of the organs and organ systems considered. Depending on the cancer site, Dosimetry System 1986 (DS86) organ or kerma doses were used for computing risk estimates. Analyses were based on a general excess relative risk model (the background rate times one plus the excess relative risk). Analyses carried out for each site involved fitting the background model with no dose effect, a linear dose-response model with no effect modifiers, a linear-quadratic dose-response model with no effect modifiers, and a series of linear dose-response models that included each of the covariates (sex, age at exposure, time since exposure, attained age and city) individually as effect modifiers. Because the tumor registries ascertain cancers in the registry catchment areas only, an adjustment was made for the effects of migration. In agreement with prior LSS findings, a statistically significant excess risk for all solid cancers was demonstrated [excess relative risk at 1 Sv (ERR1Sv) = 0.63; excess absolute risk (EAR) per 10(4) person-year sievert (PY Sv) = 29.7]. For cancers of the stomach (ERR1SV = 0.32), colon (ERR1SV = 0.72), lung (ERR1SV = 0.95), breast (ERR1SV = 1.59), ovary (ERR1SV = 0.99), urinary bladder (ERR1SV = 1.02) and thyroid (ERR1SV = 1.15), significant radiation associations were observed. There was some indication of an increase in tumors of the neural tissue (excluding the brain) among persons exposed to the bombs before age 20. For the first time, radiation has been associated with liver (ERR1SV = 0.49) and nonmelanoma skin (ERR1SV = 1.0) cancer incidence in the LSS cohort. The present analysis also strengthened earlier findings, based on a smaller number of cases, of an effect of A-bomb radiation on salivary gland cancer.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8127952

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  136 in total

Review 1.  Hormesis, an update of the present position.

Authors:  Lennart Johansson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-26       Impact factor: 9.236

2.  Risk quantification.

Authors:  A M Kellerer
Journal:  Radiat Environ Biophys       Date:  2003-04       Impact factor: 1.925

3.  Lung cancer mortality among nuclear workers of the Mayak facilities in the former Soviet Union. An updated analysis considering smoking as the main confounding factor.

Authors:  M Kreisheimer; M E Sokolnikov; N A Koshurnikova; V F Khokhryakov; S A Romanow; N S Shilnikova; P V Okatenko; E A Nekolla; A M Kellerer
Journal:  Radiat Environ Biophys       Date:  2003-07-08       Impact factor: 1.925

4.  Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.

Authors:  W Rühm; L Walsh; M Chomentowski
Journal:  Radiat Environ Biophys       Date:  2003-07-03       Impact factor: 1.925

Review 5.  Update on meningiomas.

Authors:  Santosh Saraf; Bridget J McCarthy; J Lee Villano
Journal:  Oncologist       Date:  2011-10-25

6.  Functional single-nucleotide polymorphisms in the BRCA1 gene and risk of salivary gland carcinoma.

Authors:  Li Xu; Phi C Doan; Qingyi Wei; Guojun Li; Erich M Sturgis
Journal:  Oral Oncol       Date:  2012-04-12       Impact factor: 5.337

Review 7.  Cancer risk related to gastrointestinal diagnostic radiation exposure.

Authors:  Mimi L Chang; Jason K Hou
Journal:  Curr Gastroenterol Rep       Date:  2011-10

8.  Solid tumor risks after high doses of ionizing radiation.

Authors:  Rainer K Sachs; David J Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

9.  Evidence of delayed gastrointestinal syndrome in high-dose irradiated mice.

Authors:  Catherine Booth; Gregory Tudor; Nicola Tonge; Terez Shea-Donohue; Thomas J MacVittie
Journal:  Health Phys       Date:  2012-10       Impact factor: 1.316

10.  Radiation dose to the brain and subsequent risk of developing brain tumors in pediatric patients undergoing interventional neuroradiology procedures.

Authors:  I Thierry-Chef; S L Simon; C E Land; D L Miller
Journal:  Radiat Res       Date:  2008-11       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.